An optimal dosing schedule for a novel combination antimetabolite, TAS-102, based on its intracellular metabolism and its incorporation into DNA.

Source:http://linkedlifedata.com/resource/pubmed/id/14719131

Download in:

View as

General Info

PMID
14719131